Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontransmembrane transporter activity

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC15A5 SLC6A11 KCNK13 SLC16A9 P2RX5 SLC16A1 SLC44A3 SLC9B2

2.80e-0911802913GO:0022857
GeneOntologyMolecularFunctiontransporter activity

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC15A5 SLC6A11 KCNK13 SLC16A9 P2RX5 SLC16A1 SLC44A3 SLC9B2

8.16e-0912892913GO:0005215
GeneOntologyMolecularFunctionmonoatomic cation transmembrane transporter activity

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC6A11 KCNK13 P2RX5 SLC16A1 SLC9B2

1.75e-086642910GO:0008324
GeneOntologyMolecularFunctionsymporter activity

SLC6A2 SLC6A4 SLC15A5 SLC6A11 SLC16A9 SLC16A1

6.69e-08150296GO:0015293
GeneOntologyMolecularFunctionmonoatomic ion transmembrane transporter activity

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC6A11 KCNK13 P2RX5 SLC16A1 SLC9B2

9.30e-087932910GO:0015075
GeneOntologyMolecularFunctioninorganic cation transmembrane transporter activity

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC6A11 KCNK13 SLC16A1 SLC9B2

1.60e-07627299GO:0022890
GeneOntologyMolecularFunctionsecondary active transmembrane transporter activity

SLC6A2 SLC6A4 SLC15A5 SLC6A11 SLC16A9 SLC16A1 SLC9B2

1.73e-07296297GO:0015291
GeneOntologyMolecularFunctioninorganic molecular entity transmembrane transporter activity

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC6A11 KCNK13 SLC16A1 SLC9B2

7.89e-07758299GO:0015318
GeneOntologyMolecularFunctionsodium:chloride symporter activity

SLC6A2 SLC6A4 SLC6A11

1.85e-0617293GO:0015378
GeneOntologyMolecularFunctionmonoatomic anion:sodium symporter activity

SLC6A2 SLC6A4 SLC6A11

2.63e-0619293GO:0015373
GeneOntologyMolecularFunctionmetal ion transmembrane transporter activity

SLC6A2 SLC6A4 CACNA1B CACNA1E SLC6A11 KCNK13 SLC9B2

3.55e-06465297GO:0046873
GeneOntologyMolecularFunctionactive transmembrane transporter activity

SLC6A2 SLC6A4 SLC15A5 SLC6A11 SLC16A9 SLC16A1 SLC9B2

4.20e-06477297GO:0022804
GeneOntologyMolecularFunctionchloride:monoatomic cation symporter activity

SLC6A2 SLC6A4 SLC6A11

4.78e-0623293GO:0015377
GeneOntologyMolecularFunctionmonoatomic anion:monoatomic cation symporter activity

SLC6A2 SLC6A4 SLC6A11

7.00e-0626293GO:0015296
GeneOntologyMolecularFunctionmonoatomic cation channel activity

SLC6A4 CACNA1B OTOP1 CACNA1E KCNK13 P2RX5

8.37e-06343296GO:0005261
GeneOntologyMolecularFunctionsolute:monoatomic cation symporter activity

SLC6A2 SLC6A4 SLC6A11 SLC16A1

2.54e-05119294GO:0015294
GeneOntologyMolecularFunctionmonoatomic ion channel activity

SLC6A4 CACNA1B OTOP1 CACNA1E KCNK13 P2RX5

4.33e-05459296GO:0005216
GeneOntologyMolecularFunctionmonoatomic anion transmembrane transporter activity

SLC6A2 SLC6A4 SLC6A11 P2RX5

6.44e-05151294GO:0008509
GeneOntologyMolecularFunctionactive monoatomic ion transmembrane transporter activity

SLC6A2 SLC6A4 SLC6A11 SLC16A1 SLC9B2

6.64e-05301295GO:0022853
GeneOntologyMolecularFunctionvoltage-gated calcium channel activity involved in regulation of cytosolic calcium levels

CACNA1B CACNA1E

7.29e-059292GO:0099511
GeneOntologyMolecularFunctionvoltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels

CACNA1B CACNA1E

7.29e-059292GO:0099626
GeneOntologyMolecularFunctionchannel activity

SLC6A4 CACNA1B OTOP1 CACNA1E KCNK13 P2RX5

9.11e-05525296GO:0015267
GeneOntologyMolecularFunctionpassive transmembrane transporter activity

SLC6A4 CACNA1B OTOP1 CACNA1E KCNK13 P2RX5

9.21e-05526296GO:0022803
GeneOntologyMolecularFunctionsodium ion transmembrane transporter activity

SLC6A2 SLC6A4 SLC6A11 SLC9B2

1.04e-04171294GO:0015081
GeneOntologyMolecularFunctionvoltage-gated monoatomic ion channel activity

CACNA1B CACNA1E KCNK13 P2RX5

1.33e-04182294GO:0005244
GeneOntologyMolecularFunctionmonoamine transmembrane transporter activity

SLC6A2 SLC6A4

1.33e-0412292GO:0008504
GeneOntologyMolecularFunctionvoltage-gated channel activity

CACNA1B CACNA1E KCNK13 P2RX5

1.38e-04184294GO:0022832
GeneOntologyMolecularFunctionorganic hydroxy compound transmembrane transporter activity

SLC6A2 SLC6A4 SLC16A1

1.41e-0470293GO:1901618
GeneOntologyMolecularFunctionhigh voltage-gated calcium channel activity

CACNA1B CACNA1E

1.83e-0414292GO:0008331
GeneOntologyMolecularFunctionsolute:sodium symporter activity

SLC6A2 SLC6A4 SLC6A11

2.18e-0481293GO:0015370
GeneOntologyMolecularFunctionorganic cation transmembrane transporter activity

SLC6A2 SLC16A9 SLC44A3

2.34e-0483293GO:0015101
GeneOntologyMolecularFunctionmonocarboxylic acid transmembrane transporter activity

SLC6A11 SLC16A9 SLC16A1

2.97e-0490293GO:0008028
GeneOntologyMolecularFunctionsecondary active monocarboxylate transmembrane transporter activity

SLC6A11 SLC16A1

3.43e-0419292GO:0015355
GeneOntologyMolecularFunctionneurotransmitter transmembrane transporter activity

SLC6A2 SLC6A4

4.20e-0421292GO:0005326
GeneOntologyMolecularFunctionchloride transmembrane transporter activity

SLC6A2 SLC6A4 SLC6A11

7.77e-04125293GO:0015108
GeneOntologyMolecularFunctiongated channel activity

CACNA1B CACNA1E KCNK13 P2RX5

1.31e-03334294GO:0022836
GeneOntologyMolecularFunctionvoltage-gated monoatomic cation channel activity

CACNA1B CACNA1E KCNK13

1.37e-03152293GO:0022843
GeneOntologyMolecularFunctioninorganic anion transmembrane transporter activity

SLC6A2 SLC6A4 SLC6A11

1.91e-03171293GO:0015103
GeneOntologyMolecularFunctionvoltage-gated calcium channel activity

CACNA1B CACNA1E

2.03e-0346292GO:0005245
GeneOntologyMolecularFunctionproton transmembrane transporter activity

OTOP1 SLC16A1 SLC9B2

2.51e-03188293GO:0015078
GeneOntologyMolecularFunctioncarboxylic acid transmembrane transporter activity

SLC6A11 SLC16A9 SLC16A1

3.29e-03207293GO:0046943
GeneOntologyMolecularFunctionorganic acid transmembrane transporter activity

SLC6A11 SLC16A9 SLC16A1

3.33e-03208293GO:0005342
GeneOntologyMolecularFunctionorganic anion transmembrane transporter activity

SLC6A11 SLC16A9 SLC16A1

8.62e-03293293GO:0008514
GeneOntologyMolecularFunctioncalcium channel activity

CACNA1B CACNA1E

1.50e-02129292GO:0005262
GeneOntologyMolecularFunctionantiporter activity

SLC6A4 SLC9B2

1.70e-02138292GO:0015297
GeneOntologyMolecularFunctioncalcium ion transmembrane transporter activity

CACNA1B CACNA1E

2.02e-02151292GO:0015085
GeneOntologyBiologicalProcessinorganic cation transmembrane transport

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC6A11 KCNK13 P2RX5 SLC16A1 SLC9B2

1.91e-079222810GO:0098662
GeneOntologyBiologicalProcessmonoatomic cation transmembrane transport

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC6A11 KCNK13 P2RX5 SLC16A1 SLC9B2

2.33e-079422810GO:0098655
GeneOntologyBiologicalProcessinorganic ion transmembrane transport

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC6A11 KCNK13 P2RX5 SLC16A1 SLC9B2

4.73e-0710172810GO:0098660
GeneOntologyBiologicalProcessmonoatomic ion transmembrane transport

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC6A11 KCNK13 P2RX5 SLC16A1 SLC9B2

1.10e-0611152810GO:0034220
GeneOntologyBiologicalProcessmonoatomic cation transport

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC6A11 KCNK13 P2RX5 SLC16A1 SLC9B2

1.54e-0611572810GO:0006812
GeneOntologyBiologicalProcessmonoatomic ion transport

SLC6A2 SLC6A4 CACNA1B OTOP1 CACNA1E SLC6A11 KCNK13 P2RX5 SLC16A1 SLC9B2

7.21e-0613742810GO:0006811
GeneOntologyBiologicalProcessneurotransmitter reuptake

SLC6A2 SLC6A4 SLC6A11

1.83e-0538283GO:0098810
GeneOntologyBiologicalProcessneurotransmitter transport

SLC6A2 SLC6A4 CACNA1B CACNA1E SLC6A11

2.33e-05259285GO:0006836
GeneOntologyBiologicalProcesscalcium ion import across plasma membrane

CACNA1B CACNA1E P2RX5

3.72e-0548283GO:0098703
GeneOntologyBiologicalProcesscalcium ion import into cytosol

CACNA1B CACNA1E P2RX5

3.72e-0548283GO:1902656
GeneOntologyBiologicalProcessmetal ion transport

SLC6A2 SLC6A4 CACNA1B CACNA1E SLC6A11 KCNK13 P2RX5 SLC9B2

3.87e-051000288GO:0030001
GeneOntologyBiologicalProcessresponse to pain

SLC6A2 CACNA1B CACNA1E

4.47e-0551283GO:0048265
GeneOntologyBiologicalProcessneurotransmitter uptake

SLC6A2 SLC6A4 SLC6A11

4.74e-0552283GO:0001504
GeneOntologyBiologicalProcessimport into cell

SLC6A2 SLC6A4 CACNA1B CACNA1E SLC6A11 P2RX5 PTPRJ SLC9B2

6.43e-051074288GO:0098657
GeneOntologyBiologicalProcessglucose homeostasis

CACNA1E PTPRJ SLC16A1 ADIPOR2 SLC9B2

8.27e-05338285GO:0042593
GeneOntologyBiologicalProcesscarbohydrate homeostasis

CACNA1E PTPRJ SLC16A1 ADIPOR2 SLC9B2

8.39e-05339285GO:0033500
GeneOntologyBiologicalProcesssodium ion transmembrane transport

SLC6A2 SLC6A4 SLC6A11 SLC9B2

1.70e-04208284GO:0035725
GeneOntologyBiologicalProcesscalcium ion import

CACNA1B CACNA1E P2RX5

3.13e-0498283GO:0070509
GeneOntologyBiologicalProcessosteoclast development

P2RX5 SLC9B2

4.04e-0422282GO:0036035
GeneOntologyBiologicalProcessbone cell development

P2RX5 SLC9B2

4.04e-0422282GO:0098751
GeneOntologyBiologicalProcesssodium ion transport

SLC6A2 SLC6A4 SLC6A11 SLC9B2

4.92e-04275284GO:0006814
GeneOntologyBiologicalProcesstype II interferon-mediated signaling pathway

IFNGR2 OTOP1

6.11e-0427282GO:0060333
GeneOntologyBiologicalProcessmulticellular organismal response to stress

SLC6A2 CACNA1B CACNA1E

6.52e-04126283GO:0033555
GeneOntologyBiologicalProcessinorganic ion import across plasma membrane

CACNA1B CACNA1E P2RX5

9.23e-04142283GO:0099587
GeneOntologyBiologicalProcessinorganic cation import across plasma membrane

CACNA1B CACNA1E P2RX5

9.23e-04142283GO:0098659
GeneOntologyBiologicalProcessorganic cation transport

SLC6A2 SLC16A9 SLC44A3

9.80e-04145283GO:0015695
GeneOntologyBiologicalProcesssynaptic transmission, dopaminergic

SLC6A2 SLC6A4

1.03e-0335282GO:0001963
GeneOntologyBiologicalProcesspeptide transport

CACNA1E SLC15A5 SLC16A1 SLC9B2

1.27e-03355284GO:0015833
GeneOntologyBiologicalProcessosteoclast differentiation

IREB2 P2RX5 SLC9B2

1.35e-03162283GO:0030316
GeneOntologyBiologicalProcessorganic acid transmembrane transport

SLC6A11 SLC16A9 SLC16A1

1.47e-03167283GO:1903825
GeneOntologyBiologicalProcessproton transmembrane transport

OTOP1 SLC16A1 SLC9B2

1.55e-03170283GO:1902600
GeneOntologyBiologicalProcesssignal release

SLC6A4 CACNA1B CACNA1E SLC16A1 SLC9B2

1.68e-03653285GO:0023061
GeneOntologyCellularComponentpresynaptic membrane

SLC6A2 SLC6A4 CACNA1E SLC6A11

4.81e-04277284GO:0042734
GeneOntologyCellularComponentpresynapse

SLC6A2 SLC6A4 CACNA1B CACNA1E SLC6A11 SLC9B2

9.64e-04886286GO:0098793
GeneOntologyCellularComponentcytoplasmic vesicle membrane

SLC6A4 IFNGR2 UBA1 CR1 PTPRJ MMD SLC9B2

1.36e-031307287GO:0030659
GeneOntologyCellularComponentvesicle membrane

SLC6A4 IFNGR2 UBA1 CR1 PTPRJ MMD SLC9B2

1.47e-031325287GO:0012506
GeneOntologyCellularComponentvoltage-gated calcium channel complex

CACNA1B CACNA1E

1.73e-0346282GO:0005891
DomainNA_NEUROTRAN_SYMP_2

SLC6A2 SLC6A4 SLC6A11

2.43e-0618283PS00754
DomainSNF

SLC6A2 SLC6A4 SLC6A11

2.88e-0619283PF00209
DomainNA_NEUROTRAN_SYMP_3

SLC6A2 SLC6A4 SLC6A11

2.88e-0619283PS50267
DomainNa/ntran_symport

SLC6A2 SLC6A4 SLC6A11

2.88e-0619283IPR000175
DomainNA_NEUROTRAN_SYMP_1

SLC6A2 SLC6A4 SLC6A11

2.88e-0619283PS00610
DomainCa_chan_IQ

CACNA1B CACNA1E

4.53e-057282PF08763
DomainGPHH

CACNA1B CACNA1E

4.53e-057282PF16905
DomainGPHH_dom

CACNA1B CACNA1E

4.53e-057282IPR031649
DomainVDCC_a1su_IQ

CACNA1B CACNA1E

4.53e-057282IPR014873
DomainCa_chan_IQ

CACNA1B CACNA1E

4.53e-057282SM01062
DomainVDCCAlpha1

CACNA1B CACNA1E

9.68e-0510282IPR002077
DomainAdipoR/HlyIII-related

MMD ADIPOR2

1.18e-0411282IPR004254
DomainHlyIII

MMD ADIPOR2

1.18e-0411282PF03006
DomainMFS_dom

SLC15A5 SLC16A9 SLC16A1

1.04e-03134283IPR020846
Domainfn3

IFNGR2 SDK2 PTPRJ

1.79e-03162283PF00041
DomainFN3

IFNGR2 SDK2 PTPRJ

2.61e-03185283SM00060
DomainFN3

IFNGR2 SDK2 PTPRJ

3.21e-03199283PS50853
DomainChannel_four-helix_dom

CACNA1B CACNA1E

3.29e-0357282IPR027359
Domain-

CACNA1B CACNA1E

3.29e-03572821.20.120.350
DomainFN3_dom

IFNGR2 SDK2 PTPRJ

3.68e-03209283IPR003961
DomainMFS

SLC16A9 SLC16A1

5.92e-0377282IPR011701
DomainMFS_1

SLC16A9 SLC16A1

5.92e-0377282PF07690
DomainMFS

SLC16A9 SLC16A1

1.14e-02108282PS50850
DomainIon_trans_dom

CACNA1B CACNA1E

1.26e-02114282IPR005821
DomainIon_trans

CACNA1B CACNA1E

1.26e-02114282PF00520
PathwayREACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS

SLC6A2 SLC6A11 SLC16A1 SLC44A3

4.35e-0676214MM15072
PathwayREACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS

SLC6A2 SLC6A11 SLC16A1 SLC44A3

6.50e-0684214M27334
PathwayWP_NRF2_PATHWAY

SLC6A2 SLC6A4 SLC6A11 PTGR1

5.03e-05141214M39454
PathwayREACTOME_NEURONAL_SYSTEM

SLC6A4 CACNA1B CACNA1E SLC6A11 KCNK13

1.09e-04335215MM14503
PathwayKEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY

CACNA1B CACNA1E

1.15e-0411212M47958
PathwayREACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING

CACNA1B CACNA1E

1.15e-0411212MM14498
PathwayREACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING

CACNA1B CACNA1E

1.15e-0411212M26913
PathwayREACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES

SLC6A4 CACNA1B CACNA1E SLC6A11

2.39e-04211214MM14502
PathwayREACTOME_NEURONAL_SYSTEM

SLC6A4 CACNA1B CACNA1E SLC6A11 KCNK13

2.84e-04411215M735
PathwayREACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS

SLC6A2 SLC6A11

3.56e-0419212MM15107
PathwayREACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS

SLC6A2 SLC6A11

3.56e-0419212M27362
PathwayREACTOME_TRANSPORT_OF_SMALL_MOLECULES

SLC6A2 IREB2 SLC6A11 SLC16A1 SLC44A3 SLC9B2

3.61e-04681216MM14985
PathwayREACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT

SLC6A2 SLC6A11 SLC16A1 SLC44A3

3.78e-04238214MM15076
PathwayREACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT

SLC6A2 SLC6A11 SLC16A1 SLC44A3

4.49e-04249214M5988
PathwayKEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY

CACNA1B CACNA1E

5.25e-0423212M47666
PathwayREACTOME_TRANSPORT_OF_SMALL_MOLECULES

SLC6A2 IREB2 SLC6A11 SLC16A1 SLC44A3 SLC9B2

5.48e-04736216M27287
PathwayREACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES

SLC6A4 CACNA1B CACNA1E SLC6A11

6.09e-04270214M15514
PathwayKEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL

CACNA1B CACNA1E

6.21e-0425212M47948
PathwayWP_MONOAMINE_TRANSPORT

SLC6A2 SLC6A4

1.02e-0332212M39724
PathwayWP_NUCLEAR_RECEPTORS_METAPATHWAY

SLC6A2 SLC6A4 SLC6A11 PTGR1

1.07e-03314214M39428
PathwayKEGG_TYPE_II_DIABETES_MELLITUS

CACNA1B CACNA1E

2.19e-0347212M19708
PathwayKEGG_CALCIUM_SIGNALING_PATHWAY

CACNA1B CACNA1E P2RX5

2.23e-03178213M2890
PathwayWP_SYNAPTIC_VESICLE_PATHWAY

SLC6A4 CACNA1B

2.58e-0351212M39457
PathwayKEGG_LEISHMANIA_INFECTION

IFNGR2 CR1

5.07e-0372212M3126
PathwayREACTOME_INTEGRATION_OF_ENERGY_METABOLISM

CACNA1E ADIPOR2

5.07e-0372212MM14631
PathwayWP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL

CACNA1B SLC16A1

5.21e-0373212MM16641
Pubmed

SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome.

SLC6A2 SLC6A4

6.71e-07229225295552
Pubmed

Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.

SLC6A2 SLC6A4

6.71e-07229215337646
Pubmed

[Association of serotonin and norepinephrine transporter gene polymorphisms with the susceptibility to depression].

SLC6A2 SLC6A4

6.71e-07229220017301
Pubmed

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.

SLC6A2 SLC6A4

6.71e-07229225650523
Pubmed

Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance.

CACNA1B CACNA1E

6.71e-07229215610184
Pubmed

Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.

SLC6A2 SLC6A4

6.71e-07229219468717
Pubmed

Effects of ablation of N- and R-type Ca(2+) channels on pain transmission.

CACNA1B CACNA1E

6.71e-07229212074836
Pubmed

Norepinephrine and serotonin transporter genes: impact on treatment response in depression.

SLC6A2 SLC6A4

6.71e-07229220588071
Pubmed

A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.

SLC6A2 SLC6A4

6.71e-07229221129446
Pubmed

Combination of the serotonin transporter and norepinephrine transporter gene promoter polymorphisms might influence harm avoidance and novelty seeking in healthy females.

SLC6A2 SLC6A4

6.71e-07229218511195
Pubmed

Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.

SLC6A2 SLC6A4

6.71e-07229224346757
Pubmed

Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.

SLC6A2 SLC6A4

6.71e-07229223086945
Pubmed

[Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].

SLC6A2 SLC6A4

6.71e-07229220491280
Pubmed

The repertoire of solute carriers of family 6: identification of new human and rodent genes.

SLC6A2 SLC6A4 SLC6A11

6.86e-072129316125675
Pubmed

Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.

SLC6A2 SLC6A4

2.01e-06329212401330
Pubmed

The intracellular C-terminus confers compartment-specific targeting of voltage-gated calcium channels.

CACNA1B CACNA1E

2.01e-06329238996073
Pubmed

Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.

SLC6A2 SLC6A4

2.01e-06329219482066
Pubmed

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression.

SLC6A2 SLC6A4

2.01e-06329219649213
Pubmed

Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas.

SLC6A2 SLC6A4

2.01e-06329220332182
Pubmed

Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics.

CACNA1B CACNA1E

2.01e-06329224523520
Pubmed

Cellular expression of the monocarboxylate transporter (MCT) family in the placenta of mice.

SLC16A9 SLC16A1

2.01e-06329220022372
Pubmed

Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders.

SLC6A2 SLC6A4

2.01e-06329215138209
Pubmed

Serotonin transporter gene and adverse life events in adult ADHD.

SLC6A2 SLC6A4

2.01e-06329218214863
Pubmed

Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry.

CACNA1B CACNA1E

4.02e-06429232616470
Pubmed

Cerebellar granule cell signaling is indispensable for normal motor performance.

CACNA1B CACNA1E

4.02e-06429237141091
Pubmed

Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.

SLC6A2 SLC6A4

4.02e-06429218937309
Pubmed

Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1.

SLC6A2 SLC6A4

4.02e-06429211343649
Pubmed

Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans.

SLC6A2 SLC6A4

4.02e-06429216848906
Pubmed

Chromosomal localization of the human genes for alpha 1A, alpha 1B, and alpha 1E voltage-dependent Ca2+ channel subunits.

CACNA1B CACNA1E

6.70e-0652928825650
Pubmed

Functional disorders of the sympathetic nervous system in mice lacking the alpha 1B subunit (Cav 2.2) of N-type calcium channels.

CACNA1B CACNA1E

6.70e-06529211296258
Pubmed

Antinociceptive effect of different types of calcium channel inhibitors and the distribution of various calcium channel alpha 1 subunits in the dorsal horn of spinal cord in mice.

CACNA1B CACNA1E

6.70e-06529215451373
Pubmed

Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers.

SLC6A2 SLC6A4

6.70e-06529218197080
Pubmed

An action potential initiation mechanism in distal axons for the control of dopamine release.

CACNA1B CACNA1E

1.00e-05629235324301
Pubmed

Direct interaction of gbetagamma with a C-terminal gbetagamma-binding domain of the Ca2+ channel alpha1 subunit is responsible for channel inhibition by G protein-coupled receptors.

CACNA1B CACNA1E

1.00e-0562929238069
Pubmed

Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.

SLC6A2 SLC6A4

1.00e-05629220858707
Pubmed

Expression and immunolocalization of the plasma membrane monoamine transporter in the brain.

SLC6A2 SLC6A4

1.00e-05629217408864
Pubmed

Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis.

CACNA1B CACNA1E

1.00e-05629212827191
Pubmed

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.

SLC6A2 SLC6A4

1.00e-05629219858760
Pubmed

Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.

SLC6A2 SLC6A4

1.00e-05629215135235
Pubmed

A transient placental source of serotonin for the fetal forebrain.

SLC6A4 SLC16A1

1.41e-05729221512572
Pubmed

Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.

SLC6A2 SLC6A4

1.41e-05729219844206
Pubmed

Rebuilding essential active zone functions within a synapse.

CACNA1B CACNA1E

1.41e-05729235176221
Pubmed

Evolutionary insights into T-type Ca2+ channel structure, function, and ion selectivity from the Trichoplax adhaerens homologue.

CACNA1B CACNA1E

1.87e-05829228330839
Pubmed

Serotonin transporter protects the placental cells against apoptosis in caspase 3-independent pathway.

SLC6A2 SLC6A4

1.87e-05829228109119
Pubmed

International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.

CACNA1B CACNA1E

2.41e-05929216382099
Pubmed

IRIP, a new ischemia/reperfusion-inducible protein that participates in the regulation of transporter activity.

SLC6A2 SLC6A4

2.41e-05929216024787
Pubmed

PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif.

MMD ADIPOR2

3.68e-051129216044242
Pubmed

The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.

SLC16A9 SLC16A1

6.07e-051429212739169
Pubmed

A pilot multivariate parallel ICA study to investigate differential linkage between neural networks and genetic profiles in schizophrenia.

SLC6A2 SLC6A4

7.00e-051529219944766
Pubmed

Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons.

CACNA1B CACNA1E

7.00e-051529220188150
Pubmed

Differential neuronal targeting of a new and two known calcium channel β4 subunit splice variants correlates with their regulation of gene expression.

CACNA1B CACNA1E

7.00e-051529224453333
Pubmed

Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.

SLC6A2 SLC6A4

8.00e-051629219693267
Pubmed

Candidate gene studies of ADHD: a meta-analytic review.

SLC6A2 SLC6A4

1.02e-041829219506906
Pubmed

Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.

SLC6A2 SLC6A4

1.14e-041929219095219
Pubmed

Genetical genomic determinants of alcohol consumption in rats and humans.

SLC6A2 SLC6A4 SLC6A11

1.74e-0413029319874574
Pubmed

Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development.

CACNA1B CACNA1E KCNK13

2.12e-0413929316985003
Pubmed

L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparathyroidism: an application of haplotype-based analysis for multiple linked single nucleotide polymorphisms.

SLC6A2 CACNA1E SLC6A11

2.30e-0414329320424473
Pubmed

Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A.

SLC6A2 SLC6A4

2.50e-042829219352218
Pubmed

Genetic associations of brain structural networks in schizophrenia: a preliminary study.

SLC6A2 SLC6A4

3.08e-043129220691427
Pubmed

Differential gene expression profiling of the molar tooth germ in peroxisome proliferator-activated receptor-alpha (PPAR-alpha) knockout mouse and in wild-type mouse: molar tooth phenotype of PPAR-alpha knockout mouse.

CACNA1B CACNA1E

3.28e-043229219320717
Pubmed

Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.

CACNA1B CACNA1E

4.63e-043829230786075
GeneFamilySolute carriers

SLC6A2 SLC6A4 SLC15A5 SLC6A11 SLC16A9 SLC16A1 SLC44A3 SLC9B2

2.62e-08395248752
GeneFamilyProgestin and adipoQ receptor family

MMD ADIPOR2

9.22e-0511242930
GeneFamilyCalcium voltage-gated channel subunits

CACNA1B CACNA1E

5.38e-0426242253
GeneFamilyFibronectin type III domain containing

IFNGR2 SDK2 PTPRJ

1.20e-03160243555
ToppCellLPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC15A5 SLC6A11 DNAH8 NAT16

5.89e-07103294eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3
ToppCellkidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

UBA1 SLC16A9 PTPRJ YIPF3

2.31e-0614529447a3bb973a508d3097213a2d86ad1ce697af9bae
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CACNA1B CACNA1E SDK2 SLC16A9

4.04e-061672943edb0570e583bb527165bcd8a4c25a042054043b
ToppCellControl-B_cells-B_cells|Control / group, cell type (main and fine annotations)

SDK2 P2RX5 CR1 DNAH8

4.98e-06176294d2c353783bd78dc24f28e00d917b88d8294fb5df
ToppCellCOVID-19_Moderate-B_memory|COVID-19_Moderate / disease group, cell group and cell class

P2RX5 CR1 DNAJC5B DNAH8

5.69e-06182294bbdbef62389ac062118cc0c7979686393399f2c8
ToppCellCOVID-19_Severe-B_memory|World / disease group, cell group and cell class

CACNA1E P2RX5 DNAJC5B DNAH8

6.33e-06187294f29c71f2505bb64f3010ada491d422b87a6f7db3
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RX5 CR1 DNAJC5B DNAH8

6.46e-061882949256c5f45c97df209bb9c322c3b557d4f726a333
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RX5 CR1 DNAJC5B DNAH8

6.60e-06189294ac0203f17b481d608587113ea2de0f383b29ed27
ToppCell390C-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

IFNGR2 SDK2 P2RX5 CR1

6.74e-06190294f63c9474f23bb72f0bb1fc531342f0da04ed8b3e
ToppCell390C-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

IFNGR2 SDK2 P2RX5 CR1

6.74e-0619029453bf211f0e8a44f5adb89c43b210a1e35120b6a8
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

P2RX5 CR1 DNAJC5B DNAH8

6.88e-0619129403f6da73e7b706252d2096507222229c4101a27b
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_memory-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

P2RX5 CR1 DNAJC5B DNAH8

6.88e-06191294578b58782e816ecaeabfbc616ceb1dcd53ee428b
ToppCellCOVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type

IFNGR2 KCNK13 CR1 PTPRJ

7.77e-06197294a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCellmild-B_memory|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

P2RX5 CR1 DNAJC5B DNAH8

8.09e-06199294025bb65629d9e20c374e8f1ba08c36d1bb569190
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

DNAJC5B SLC44A3 SLC9B2

9.12e-051352934451c44f3ad788437f4e2ae81049fbbab53f967e
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

DNAJC5B SLC44A3 SLC9B2

9.12e-0513529345f67f33c8320d9fb6dbceae603b564f6a8ffd1e
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CACNA1B P2RX5 DNAH8

1.22e-041492932cd860b96ed4be4d26844085d464961c1418054a
ToppCellLPS-antiTNF-Hematopoietic_Mast-Mast_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1B KCNK13 MMD

1.22e-0414929359aa1f2a5cbeba64c4529fb05f544db17fd8b188
ToppCellLPS-antiTNF-Hematopoietic_Mast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1B KCNK13 MMD

1.22e-041492931527cdd98a2734cbf8ce4c6170557280b71c55cb
ToppCellLPS_only-Hematopoietic_Mast-Mast_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1B KCNK13 MMD

1.25e-04150293ccb782fbcb3122266354a112a9a850506664f44d
ToppCellLPS_only-Hematopoietic_Mast-Mast_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1B KCNK13 MMD

1.25e-041502937290e9a812b1b2f919e67ccde0acf52687ab138f
ToppCellLPS_only-Hematopoietic_Mast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1B KCNK13 MMD

1.25e-041502932c5078a1f769ba8153dee756b53d28eb7b434a96
ToppCell10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue

KCNK13 SLC16A9 CR1

1.40e-041562939a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCelldroplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC16A9 PTPRJ YIPF3

1.40e-04156293d72c2f5f72d269e29033f8728d924e0d4c8772c7
ToppCellsaliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

P2RX5 SLC16A1 ENTPD6

1.59e-0416329313f76f2979558f5cd27fbfd1659b413b3cac18f5
ToppCell3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SLC6A11 SDK2 SLC44A3

1.71e-0416729317c653b46507c8bb85da95836ae72a6015336142
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SLC15A5 KCNK13 SDK2

1.77e-041692931c9e54e7b14eb99996590fb93b257cf881a9f184
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

SLC6A4 SLC6A11 NAT16

1.86e-0417229368fd03f2c8ee01fe46194400f74ede3830e00f34
ToppCellsevere-B_memory|severe / disease stage, cell group and cell class

P2RX5 CR1 DNAJC5B

1.90e-041732933a987ac53a0136cc4c70ce8b901a15fc00c795e1
ToppCellPND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC6A4 CACNA1B CACNA1E

1.96e-041752938362a46f5804333baa84cd56d450bc147f372a7e
ToppCellPND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC6A4 CACNA1B CACNA1E

1.96e-041752938b4c62e608f0ec84e563bbf0ebffe3ed44085298
ToppCellsevere-B_memory|World / disease stage, cell group and cell class

P2RX5 CR1 DNAJC5B

2.00e-041762934e5c6b1aa5ffd13593a6bcd1e1253c1737c5c2b4
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SLC15A5 KCNK13 SDK2

2.03e-0417729362f180d5a487b449f715de49ee1e1e11c4e0cf4d
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

P2RX5 CR1 DNAH8

2.06e-041782932e51c1596022b7047994ee13c18375bad19a54a5
ToppCellTCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9

CACNA1B PTPRJ SLC9B2

2.10e-04179293431e1b29015ec817f778499106d24b19cfc825ae
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

P2RX5 CR1 DNAH8

2.17e-04181293e7d9910f6143055645b6f03b1018282e6c215f10
ToppCellURO-Lymphocyte-B-B_memory|URO / Disease, Lineage and Cell Type

P2RX5 DNAJC5B DNAH8

2.20e-041822938ffdf15230349ad53fe15bb467724d28c5a05bf6
ToppCellwk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

SLC6A2 CACNA1B P2RX5

2.27e-04184293eac2a9089913f33a961ba11519b53645790f2056
ToppCelldroplet-Bladder-BLADDER-1m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTGR1 SLC44A3 ENTPD6

2.27e-04184293382b1e90b3f437af596750669c0465a169d97095
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RX5 DNAJC5B DNAH8

2.31e-0418529391c9a3ea1afd97d35bd05648875d29b35fe09128
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RX5 DNAJC5B DNAH8

2.31e-0418529305e6eb78ead81268c1656e7ffe34f9cb7329b908
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

SLC6A11 P2RX5 DNAJC5B

2.31e-0418529353960307c6710401c3d52a766c3f4704ace9637f
ToppCell10x5'-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue

IFNGR2 P2RX5 CR1

2.35e-04186293a5c0bd4f6a7542f67d478dcdc0645ae6d927a395
ToppCelldroplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC6A4 P2RX5 ADIPOR2

2.35e-041862938f77e552e613b6e124443c7f6ef5c1316a5ff8db
ToppCelldroplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC6A4 P2RX5 ADIPOR2

2.35e-04186293f1aa0c58336d23bcbe52a59e7af954d20085bdb6
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

P2RX5 DNAJC5B DNAH8

2.38e-0418729343f81863063509337bd56a67010c62fb51109bd5
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_memory|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)

P2RX5 DNAJC5B DNAH8

2.38e-04187293ea56cfca919a09db852b7ee5e42323f822962465
ToppCell18-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class

SLC6A4 SLC16A9 DNAJC5B

2.38e-04187293d1e301afcc39054ae1f867d80e564e30a137e3f8
ToppCell3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SLC6A2 CACNA1B CACNA1E

2.42e-04188293bd091503f580dedab40e0996273101285d24b586
ToppCellMultiple_Sclerosis-Lymphocyte-B-B_memory|Multiple_Sclerosis / Disease, Lineage and Cell Type

P2RX5 CR1 DNAJC5B

2.42e-041882938da631b2c75441b7309f03e7d4c14f15f2367be6
ToppCellControl-Lymphoid_B-B_memory|Control / Disease group, lineage and cell class

P2RX5 DNAJC5B DNAH8

2.42e-04188293ba4245de3bee29118abab57c4fce60b2007a189c
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_memory|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RX5 DNAJC5B DNAH8

2.42e-04188293b6ae707b033a17c75ca81f9194631ead1b63d170
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RX5 DNAJC5B DNAH8

2.42e-04188293cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9
ToppCellILEUM-non-inflamed-(2)_Memory_B_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

P2RX5 CR1 DNAJC5B

2.46e-041892938d9b8a952db78646f137526f3175ba502f1d3692
ToppCellremission-B_memory|remission / disease stage, cell group and cell class

P2RX5 DNAJC5B DNAH8

2.46e-04189293a7b434a5d2cc7c3952cb8f16d11219b691c6c2b6
ToppCellCOVID-19_Severe-Lymphoid_B-B_memory|COVID-19_Severe / Disease group, lineage and cell class

P2RX5 DNAJC5B DNAH8

2.50e-04190293b6510c419a15ed049c0a0a6a6697b643668741c3
ToppCellremission-B_memory|World / disease stage, cell group and cell class

P2RX5 DNAJC5B DNAH8

2.50e-04190293c3f55f752e47b5a71e111367cdbed4a39ab5cb21
ToppCellCOPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class

PTPRJ SLC16A1 DNAH8

2.54e-041912933ae18bc4e3dff49b5d5958da8ebc3f747274b69c
ToppCellCOVID-19_Convalescent-Lymphoid_B-B_memory|COVID-19_Convalescent / Disease group, lineage and cell class

P2RX5 DNAJC5B DNAH8

2.54e-041912934a853cd2434b0f5b18e1f853c37515845046c88b
ToppCellsevere_COVID-19-B_memory|World / disease group, cell group and cell class (v2)

P2RX5 DNAJC5B DNAH8

2.54e-041912933b57e353b74ebc866d0e11deeba31fa764c42325
ToppCellAdult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor

IFNGR2 KCNK13 PTPRJ

2.54e-04191293cbebb4d9550fdcd606cb3685ac9546c6b73fd422
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RX5 DNAJC5B DNAH8

2.54e-0419129322134a2c1a92208bc1629a620ce73a56502613c2
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_memory-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

P2RX5 DNAJC5B DNAH8

2.58e-04192293debd471f61cf3606b8e9c246add0be5df601af7f
ToppCellcontrol-B_memory|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

P2RX5 DNAJC5B DNAH8

2.58e-04192293d6ef271b6c4f9b49323650f3f773abd61c1b13c3
ToppCellAdult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor

KCNK13 CR1 PTPRJ

2.58e-04192293733491e932350e3c216a626cc49c3cd3fe970a82
ToppCellCOVID-19_Mild-Lymphoid_B-B_memory|COVID-19_Mild / Disease group, lineage and cell class

P2RX5 DNAJC5B DNAH8

2.58e-04192293d27db7669de95bddbea8ccb83e6f10ae7240b1ab
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

P2RX5 DNAJC5B DNAH8

2.58e-04192293314f74dd3c6d94839eed05b9a1a398217ef78029
ToppCellmoderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

IFNGR2 CR1 DNAH8

2.58e-04192293ae3727503c3b9f4695e565fd3161cc33b898f349
ToppCellVE-naiveBc-|VE / Condition, Cell_class and T cell subcluster

IFNGR2 P2RX5 DNAH8

2.58e-04192293bca2aec4811627225fccd92abe2f3b1ba729c9ce
ToppCellVE-naiveBc|VE / Condition, Cell_class and T cell subcluster

IFNGR2 P2RX5 DNAH8

2.58e-0419229387cdda9a170f6f2fa56d0ed1d3fd2f93bfe09aa1
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 PTPRJ SLC44A3

2.62e-041932933866667dd221612589ae50f5c52f73a183a49ce6
ToppCellmild_COVID-19-B_memory|World / disease group, cell group and cell class (v2)

P2RX5 DNAJC5B DNAH8

2.62e-0419329369b70c838328fdc7dbb6b5449fe2811a5389a839
ToppCellChildren_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

KCNK13 CR1 PTPRJ

2.62e-0419329358e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

P2RX5 CR1 DNAH8

2.62e-04193293de0213f2105b814f38ffbfd004ea7603230eed68
ToppCellmild_COVID-19-B_memory|mild_COVID-19 / disease group, cell group and cell class (v2)

P2RX5 DNAJC5B DNAH8

2.62e-041932937e6fe70928a50b0a8f12220e572c07c5670d092e
ToppCellCF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class

IFNGR2 CR1 DNAH8

2.62e-041932937ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 PTPRJ SLC44A3

2.62e-0419329382e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCellsevere-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

P2RX5 SLC16A1 DNAH8

2.66e-041942932fee6083fb56b16d1f04fd0b92ec622fd26ba3fa
ToppCellcritical-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

IFNGR2 P2RX5 CR1

2.66e-04194293eeae611ab72d602fb545c729a14ef38ce5c47f2c
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Naive_B|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SDK2 P2RX5 CR1

2.70e-04195293f00e6d000e107daed68d3ffa8948e1f6a41eb242
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B-Memory_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue

IFNGR2 P2RX5 CR1

2.70e-041952938b307079cee67fc1df55277d0cab21ea4b97e552
ToppCellBronchial_Biopsy-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X

CR1 DNAJC5B MMD

2.70e-041952936800c17026ec6c56132bf4664b8fcd74d7836579
ToppCellCOVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type

KCNK13 CR1 PTPRJ

2.70e-04195293148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCellChildren_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor

KCNK13 CR1 PTPRJ

2.74e-04196293cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCellCOVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type

KCNK13 CR1 PTPRJ

2.74e-041962937026c1fc33425e5476063d17c79e4b79356a9e01
ToppCellCOVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type

KCNK13 CR1 PTPRJ

2.74e-04196293a753d76d764c181eecb0e17a794a2e7d0ff70136
ToppCellFetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

KCNK13 CR1 PTPRJ

2.78e-041972938b9a88fb671d5c2b25d291c851e2b8a478f2610c
ToppCellControl-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

CR1 DNAJC5B DNAH8

2.78e-04197293b86385c6c1d52ef4e3d855004d77afab61556978
ToppCellCOVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type

IFNGR2 CR1 PTPRJ

2.78e-041972933912301018d0863144dcfac8d1fa8adc081748d7
ToppCellCOVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type

KCNK13 CR1 PTPRJ

2.78e-041972933896729740d151f0eb845f1961c7b969bfbdd28d
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B|lymph-node_spleen / Manually curated celltypes from each tissue

IFNGR2 P2RX5 CR1

2.82e-041982931780fa1725a321041094e8c4430673c0a4f3d407
ToppCellControl-Control-Lymphocyte-B-B_memory|Control / Disease, condition lineage and cell class

P2RX5 DNAJC5B DNAH8

2.86e-0419929376976d5f79f324a6c488161847c50f207361d6c6
ToppCellmild-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

P2RX5 DNAJC5B DNAH8

2.86e-04199293e6ac9a0959b0de2c6a99298feb7715aa80ade1dd
ToppCellCOVID-19-COVID-19_Convalescent-Lymphocyte-B-B_memory|COVID-19_Convalescent / Disease, condition lineage and cell class

P2RX5 DNAJC5B DNAH8

2.86e-041992935bbda86486910d053ca51b9caee487d78f6462cb
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-B-B_memory|COVID-19_Mild / Disease, condition lineage and cell class

P2RX5 DNAJC5B DNAH8

2.86e-0419929354e392b4ebe601d4838739ff7de3ac6b2203c948
ToppCellMS-Multiple_Sclerosis-Lymphocyte-B-B_memory|Multiple_Sclerosis / Disease, condition lineage and cell class

P2RX5 CR1 DNAJC5B

2.86e-04199293ae2979c0d2711580863d3b751f6ff1e3abdfd90e
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-B-B_memory|COVID-19_Severe / Disease, condition lineage and cell class

P2RX5 DNAJC5B DNAH8

2.86e-0419929324c05faa825c9d55279956469862440f9914a280
ToppCellSepsis-URO-Lymphocyte-B-B_memory|URO / Disease, condition lineage and cell class

P2RX5 DNAJC5B DNAH8

2.86e-04199293040b51911a5d3b2ddd15497af2cf0ced9f271fee
ToppCellNeuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SCUBE1|Neuronal / cells hierarchy compared to all cells using T-Statistic

SLC15A5 KCNK13 SDK2

2.90e-04200293012dd2180f6f596d6e55e864be2e62b53c15edb2
ToppCellsevere-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SDK2 P2RX5 MMD

2.90e-042002930e86f52b6e146d9bbc728d8fb176fc2b53696558
ComputationalGenes in the cancer module 162.

SLC6A2 SLC6A4 SLC6A11

2.58e-0619163MODULE_162
ComputationalGenes in the cancer module 218.

SLC6A2 SLC6A4 SLC6A11

3.04e-0620163MODULE_218
Drugsipatrigine

SLC6A2 SLC6A4 CACNA1B CACNA1E SLC6A11

9.88e-1037295CID000060803
Druggastrodin

CACNA1B CACNA1E SLC6A11

3.04e-0711293CID000115067
Drug5-mm AI

SLC6A2 SLC6A4 MMD

4.06e-0712293CID000131575
Drugdiphenyl sulfide

SLC6A2 SLC6A4 MMD

6.70e-0714293CID000008766
DrugDesvenlafaxine

SLC6A2 SLC6A4

1.57e-062292DB06700
DrugMilnacipran

SLC6A2 SLC6A4

1.57e-062292DB04896
DrugAmineptine

SLC6A2 SLC6A4

1.57e-062292DB04836
Drugnorcepharadione B

CACNA1B CACNA1E

1.57e-062292CID000189168
DrugProtriptyline

SLC6A2 SLC6A4

1.57e-062292DB00344
Drugaristolactam AII

CACNA1B CACNA1E

1.57e-062292CID000148657
DrugAtomoxetine

SLC6A2 SLC6A4

1.57e-062292DB00289
Drugalkosin

CACNA1B CACNA1E

1.57e-062292CID005488638
Drugnisoxetine

SLC6A2 SLC6A4

1.57e-062292ctd:C011386
Drugpiperolactam A

CACNA1B CACNA1E

1.57e-062292CID003081016
Drug1,3-dipropylxanthine

SLC6A2 CACNA1B CACNA1E P2RX5

2.30e-0674294CID000169317
DrugD-161 compound

SLC6A2 SLC6A4

4.70e-063292ctd:C532102
DrugRTI-219

SLC6A2 SLC6A4

4.70e-063292CID010524711
DrugMazindol

SLC6A2 SLC6A4

4.70e-063292DB00579
DrugDexmethylphenidate

SLC6A2 SLC6A4

4.70e-063292DB06701
DrugMethylphenidate

SLC6A2 SLC6A4

4.70e-063292DB00422
DrugDuloxetine

SLC6A2 SLC6A4

4.70e-063292DB00476
Drug2-(4-bromo-2,5-dimethoxyphenyl)ethylamine

SLC6A2 SLC6A4

4.70e-063292ctd:C079321
Drug5-(2-aminopropyl)benzofuran

SLC6A2 SLC6A4

4.70e-063292ctd:C000608250
Drug2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone

SLC6A2 SLC6A4

4.70e-063292ctd:C569113
Drug1-phenyl-2-(1-pyrrolidinyl)-1-pentanone

SLC6A2 SLC6A4

4.70e-063292ctd:C000592273
Drug4-methoxymethamphetamine

SLC6A2 SLC6A4

4.70e-063292ctd:C060169
Drugdifluoropine

SLC6A2 SLC6A4

4.70e-063292CID000190851
Drug2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

SLC6A2 SLC6A4

4.70e-063292ctd:C554181
DrugVenlafaxine

SLC6A2 SLC6A4

4.70e-063292DB00285
Drug2-(4-bromo-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine

SLC6A2 SLC6A4

4.70e-063292ctd:C000595926
Drug4-fluoroamphetamine

SLC6A2 SLC6A4

4.70e-063292ctd:C040639
Drug1,4-diazabicyclo[3.3.1]nonane

SLC6A2 SLC6A4

4.70e-063292CID015140257
DrugSibutramine

SLC6A2 SLC6A4

4.70e-063292DB01105
Drugcalcium carbonate

SLC6A2 SLC6A4 OTOP1 SLC16A9 SLC16A1

5.35e-06203295CID000010112
DrugHis-pro-dkp

SLC6A2 SLC6A4 SLC6A11

8.15e-0631293CID000065137
Drug3-aminopropylphosphinic acid

CACNA1B CACNA1E SLC6A11

8.99e-0632293CID006335948
DrugAC 110

CACNA1B CACNA1E

9.38e-064292CID000022860
Drug4-(4-Chlorophenyl)piperidine

SLC6A2 SLC6A4

9.38e-064292CID001203613
Drug[18f]fmener-d2

SLC6A2 SLC6A4

9.38e-064292CID006914301
DrugFluorescent Dyes

SLC6A2 SLC6A4

9.38e-064292ctd:D005456
Drugindatraline

SLC6A2 SLC6A4

9.38e-064292ctd:C418119
Drugbutriptyline

SLC6A2 SLC6A4

9.38e-064292CID000021771
DrugBiogenic Monoamines

SLC6A2 SLC6A4

9.38e-064292ctd:D015306
DrugChlorpheniramine

SLC6A2 SLC6A4

9.38e-064292DB01114
Drugalmagel

CACNA1B CACNA1E

1.56e-055292CID003080942
Drug[11c]afa

SLC6A2 SLC6A4

1.56e-055292CID005352128
Drug[11c]afm

SLC6A2 SLC6A4

1.56e-055292CID005352125
DrugPhentermine

SLC6A2 SLC6A4

1.56e-055292DB00191
Druglortalamine

SLC6A2 SLC6A4

1.56e-055292CID000051047
Drug[11c]afe

SLC6A2 SLC6A4

1.56e-055292CID005732447
Drugdoxepin

SLC6A2 SLC6A4 SLC6A11

1.78e-0540293CID000003158
Drugdesvenlafaxine

SLC6A2 SLC6A4 SLC6A11

1.92e-0541293CID000125017
DrugAC1L9NDJ

SLC6A2 SLC6A4

2.34e-056292CID000449667
Drug3,4-dihydroquinazoline

CACNA1B CACNA1E

2.34e-056292CID000583065
Drug3 MMA

SLC6A4 MMD

2.34e-056292CID000130136
DrugMianserin

SLC6A2 SLC6A4

2.34e-056292DB06148
Drugalpha-sialylcholesterol

CACNA1B CACNA1E

2.34e-056292CID000133976
DrugClomipramine

SLC6A2 SLC6A4

2.34e-056292DB01242
DrugEscitalopram

SLC6A2 SLC6A4

2.34e-056292DB01175
Drugmaprotiline

SLC6A2 SLC6A4 SLC6A11

2.38e-0544293CID000004011
Drugamoxapine

SLC6A2 SLC6A4 SLC6A11

2.72e-0546293CID000002170
Drugpseudoisocyanin

SLC6A2 SLC6A4

3.28e-057292CID000075462
Drugoracaine

SLC6A2 SLC6A4

3.28e-057292CID000004065
Drug3,4-Methylenedioxymethamphetamine

SLC6A2 SLC6A4

3.28e-057292DB01454
DrugMMDA

SLC6A2 SLC6A4

3.28e-057292DB01442
DrugPseudoephedrine

SLC6A2 SLC6A4

3.28e-057292DB00852
DrugAPMPA

CACNA1B CACNA1E

3.28e-057292CID000512300
DrugAC1Q5UBL

SLC6A2 SLC6A4 CACNA1B SLC6A11

3.40e-05146294CID000005466
DrugAmoxapine

SLC6A2 SLC6A4

4.37e-058292DB00543
DrugRTI-121

SLC6A2 SLC6A4

4.37e-058292CID000122190
DrugAC1L1GIZ

SLC6A2 SLC6A4

4.37e-058292CID000003703
DrugCocaine

SLC6A2 SLC6A4

4.37e-058292DB00907
DrugParoxetine

SLC6A2 SLC6A4

4.37e-058292DB00715
DrugOctopamine

SLC6A2 SLC6A4

4.37e-058292ctd:D009655
Drugphenethylamine

SLC6A2 SLC6A4

5.61e-059292ctd:C029261
DrugTramadol

SLC6A2 SLC6A4

5.61e-059292DB00193
DrugNefazodone

SLC6A2 SLC6A4

5.61e-059292DB01149
Drugxylamine

SLC6A2 SLC6A4

5.61e-059292CID000005706
Drugnortriptyline

SLC6A2 SLC6A4 SLC6A11

5.76e-0559293CID000004543
Druggabapentin

CACNA1B CACNA1E IREB2 SLC6A11

6.02e-05169294CID000003446
Drugpyrrolidine-2,4-dicarboxylate

SLC6A2 SLC6A4 SLC6A11

6.36e-0561293CID000003868
Drughydride

SLC6A2 CACNA1B CACNA1E PTGR1 SLC16A1 MMD SLC9B2

6.70e-05835297CID000000783
Drugdemethoxymitomycin A

SLC6A2 SLC6A4

7.00e-0510292CID000037972
DrugNSC671195

SLC6A2 SLC6A4

7.00e-0510292CID000122834
DrugMethamphetamine

SLC6A2 SLC6A4

7.00e-0510292DB01577
Drugsmilageninoside

CACNA1B CACNA1E

7.00e-0510292CID000197391
Drug2-hydroxydesipramine

SLC6A2 SLC6A4

7.00e-0510292CID000121249
Drugmethcathinone

SLC6A2 SLC6A4

7.00e-0510292CID000001576
DrugNO-711

SLC6A2 SLC6A4 SLC6A11

8.05e-0566293CID000004515
Drug[11c]dasb

SLC6A2 SLC6A4

8.55e-0511292CID000656408
DrugImipramine

SLC6A2 SLC6A4

8.55e-0511292DB00458
Drug4-hydroxy-3-methoxymethamphetamine

SLC6A2 SLC6A4

8.55e-0511292CID003081137
DrugTrimipramine

SLC6A2 SLC6A4

8.55e-0511292DB00726
Drugleys

CACNA1B CACNA1E

8.55e-0511292CID000484683
DrugN-(2-chloroethyl)-N-ethyl-2-bromobenzylamine

SLC6A2 SLC6A4 SLC6A11

9.20e-0569293CID000003172
Drugbaclofen

CACNA1B CACNA1E SLC6A11 KCNK13

9.67e-05191294CID000002284
Drug1-4a

SLC6A2 SLC6A4 IREB2

1.00e-0471293CID000657007
Drugcreatine

SLC6A2 SLC6A4 SLC6A11 MMD

1.01e-04193294CID000000586
DrugNortriptyline

SLC6A2 SLC6A4

1.03e-0412292DB00540
DrugFP-CIT

SLC6A2 SLC6A4

1.03e-0412292CID000122197
Diseasefamilial hemiplegic migraine 1 (implicated_via_orthology)

CACNA1B CACNA1E

2.60e-063282DOID:0111181 (implicated_via_orthology)
Diseasemigraine (implicated_via_orthology)

CACNA1B CACNA1E

5.20e-064282DOID:6364 (implicated_via_orthology)
DiseaseDepressive Disorder, Treatment-Resistant

SLC6A2 SLC6A4

8.67e-065282C2063866
Diseasehereditary ataxia (implicated_via_orthology)

CACNA1B CACNA1E

1.82e-057282DOID:0050951 (implicated_via_orthology)
DiseaseRecurrent depression

SLC6A2 SLC6A4

3.11e-059282C0221480
Diseasehyperinsulinism (biomarker_via_orthology)

IREB2 ADIPOR2

9.05e-0515282DOID:2018 (biomarker_via_orthology)
DiseaseBipolar Disorder

SLC6A2 SLC6A4 CACNA1B DNAH8

1.02e-03477284C0005586
DiseaseSeizures

SLC6A2 CACNA1B CACNA1E

1.14e-03218283C0036572
DiseaseManic

SLC6A4 DNAH8

2.49e-0378282C0338831

Protein segments in the cluster

PeptideGeneStartEntry
CFEAGIKIVALGFIF

CACNA1E

136

Q15878
KALFVIVGLLTGCYF

DNAJC5B

111

Q9UF47
YFIGIFCFEAGIKII

CACNA1B

136

Q00975
FCFEAGIKIIALGFV

CACNA1B

141

Q00975
KVVFGLFFLGAILCL

ADIPOR2

181

Q86V24
LSKLGFEIVGYGCSI

IREB2

566

P48200
CGVVLIISGIYLFIG

SLC16A1

426

P53985
FFSYGIVVGLGCGLL

SLC16A9

106

Q7RTY1
IGGLFPGTKYCFEIV

PTPRJ

506

Q12913
FCQVGLGLELVKGYT

NAT16

346

Q8N8M0
ASIDKIFGIIGCGYF

DNAH8

2601

Q96JB1
VGGKIFLIFYGLVGC

KCNK13

121

Q9HB14
LIYCLGVVFFKSDGI

MMD

186

Q15546
AVITVILGCLKIGYF

OTOP1

141

Q7RTM1
ILGCLKIGYFIGFSE

OTOP1

146

Q7RTM1
YNGKLYVFGGVCVIL

KLHL15

486

Q96M94
ICDPGYLLVGKGFIF

CR1

1876

P17927
YLLVGKGFIFCTDQG

CR1

1881

P17927
VLAGACFFLVLKYRG

IFNGR2

261

P38484
FGDFIIFLGKVLVVC

SLC44A3

531

Q8N4M1
IFLGKVLVVCFTVFG

SLC44A3

536

Q8N4M1
GILKGYIIRYCLAGL

SDK2

721

Q58EX2
GFGCFTGALLVKLVY

SLC15A5

476

A6NIM6
GLTAYFGLLEICGVK

PTGR1

126

Q14914
GKGAFFCDLVLIYLI

P2RX5

326

Q93086
CPFFKGVGYAVILIA

SLC6A2

131

P23975
AKVAYPLGLCVGVFI

ENTPD6

41

O75354
FGIIILFYCAIIGGK

SLC9B2

116

Q86UD5
LFYCAIIGGKLLGLI

SLC9B2

121

Q86UD5
PGICAGIFIFFLIKY

SLC6A11

521

P48066
YFLVGAGAIGCELLK

UBA1

471

P22314
LLGYGLFGHCIVLFI

YIPF3

221

Q9GZM5
PIFKGIGYAICIIAF

SLC6A4

156

P31645
FFTIVGLLFAGKVCL

MOSMO

151

Q8NHV5